A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study)-Reference-Cited by-同舟云学术

A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study)

Published:2014-07-11 Issue:2 Volume:167 Page:243-251
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Tran Huyen¹²,Brighton Tim³,Grigg Andrew⁴,McRae Simon⁵,Dixon Joanna⁶,Thurley Daniel⁶,Gandhi Maher K.⁷⁸,Truman Matt⁶,Marlton Paula⁷⁸,Catalano John⁹

Affiliation:

1. Monash Medical Centre; Clayton Vic. Australia

2. Australian Centre for Bloods Diseases; Monash University; Melbourne Vic. Australia

3. The Prince of Wales Hospital; Randwick NSW Australia

4. Austin Hospital; Heidelberg West Vic. Australia

5. The Queen Elizabeth Hospital; Woodville SA Australia

6. Roche Products; Dee Why NSW Australia

7. Princess Alexandra Hospital; Woollongaba Qld Australia

8. School of Medicine; University of Queensland; Brisbane Qld Australia

9. Frankston Haematology & Oncology; Frankston Vic. Australia

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13029/fullpdf

Reference33 articles.

1. Rituximab in immune thrombocytopenia: transient responses, low rate of sustained remissions and poor response to further therapy in refractory patients;Aleem;International Journal of Hematology,2010

2. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura;Arnold;Annals of Internal Medicine,2007

3. A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia;Arnold;Blood,2012

4. Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis;Auger;British Journal of Haematology,2012

5. Therapy of chronic idiopathic thrombocytopenic purpura in adults;Berchtold;Blood,1989

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone + Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic, Refractory, and Relapsed Immune Thrombocytopenia Patients;Pharmaceuticals;2023-08-29

2. Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?;Frontiers in Immunology;2022-08-08

3. Low‐dose rituximab in immune thrombocytopenia: One and done;American Journal of Hematology;2022-02-15

4. The Efficacy and Safety of Different Dosages of Rituximab for Adults with Immune Thrombocytopenia: A Systematic Review and Meta-Analysis;BioMed Research International;2021-10-06

5. Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice;Journal of Blood Medicine;2021-07